As previously reported, BofA analyst Joshua Dennerlein downgraded Medical Properties Trust to Neutral from Buy with a price target of $10, down from $13. While the valuation is now "compelling," BofA says Medical Properties "has become a show me story" and the firm needs to see a positive resolution to Prospect and improvements in debt costs to be sure the company can avoid dilutive refinancing or asset sales.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MPW:
- Medical Properties Trust downgraded to Neutral from Buy at BofA
- 10 Stocks to Buy Before Their Ex-Dividend Dates Arrive, Week of March 13, 2023
- Medical Properties Stock (NYSE:MPW): Short Sellers Banking on a Dividend Cut
- Medical Properties Trust price target lowered to $14 from $17 at Barclays
- Medical Properties Trust Earnings Report: Did it Beat Expectations?